Michael J. Robertson
Lymphoma Program
Indiana University School of Medicine
535 Barnhill Drive
Indianapolis
USA
Name/email consistency: high
- A dose-escalation study of recombinant human interleukin-18 using two different schedules of administration in patients with cancer. Robertson, M.J., Kirkwood, J.M., Logan, T.F., Koch, K.M., Kathman, S., Kirby, L.C., Bell, W.N., Thurmond, L.M., Weisenbach, J., Dar, M.M. Clin. Cancer Res. (2008)
- Clinical and biological effects of recombinant human interleukin-18 administered by intravenous infusion to patients with advanced cancer. Robertson, M.J., Mier, J.W., Logan, T., Atkins, M., Koon, H., Koch, K.M., Kathman, S., Pandite, L.N., Oei, C., Kirby, L.C., Jewell, R.C., Bell, W.N., Thurmond, L.M., Weisenbach, J., Roberts, S., Dar, M.M. Clin. Cancer Res. (2006)
- Impaired interferon-gamma production as a consequence of STAT4 deficiency after autologous hematopoietic stem cell transplantation for lymphoma. Robertson, M.J., Chang, H.C., Pelloso, D., Kaplan, M.H. Blood (2005)
- Lymphocyte subset differences in patients with chronic fatigue syndrome, multiple sclerosis and major depression. Robertson, M.J., Schacterle, R.S., Mackin, G.A., Wilson, S.N., Bloomingdale, K.L., Ritz, J., Komaroff, A.L. Clin. Exp. Immunol. (2005)
- Augmented high-dose regimen of cyclophosphamide, carmustine, and etoposide with autologous hematopoietic stem cell transplantation for relapsed and refractory aggressive non-Hodgkin's lymphoma. Robertson, M.J., Abonour, R., Hromas, R., Nelson, R.P., Fineberg, N.S., Cornetta, K. Leuk. Lymphoma (2005)
- Role of chemokines in the biology of natural killer cells. Robertson, M.J. J. Leukoc. Biol. (2002)
- Are natural killer cells the key to treating Epstein-Barr virus-associated lymphoproliferative disorders?. Robertson, M.J. J. Clin. Invest. (2001)
- Regulation of human natural killer cell migration and proliferation by the exodus subfamily of CC chemokines. Robertson, M.J., Williams, B.T., Christopherson, K., Brahmi, Z., Hromas, R. Cell. Immunol. (2000)